SP-MHCI-0690-3

Escherichia coli Beta-galactosidase 1 103-109, DAPIYTNV

US$507.00

In stock

Description

About Escherichia coli Beta-galactosidase 1 103-109, DAPIYTNV

The Escherichia coli Beta-galactosidase 1 Peptide (IEDB: 138838) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Beta-galactosidase Peptide, H-DAPIYTNV-OH (Uniprot: P00722 aa: 103-109) from JPT is produced under strict quality control and quality management.

Escherichia coli Beta-galactosidase 1 103-109, DAPIYTNV - Specifications

  • Peptide sequence: H-DAPIYTNV-OH
  • Amount: 10 mg (10 x 1 mg)
  • Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
  • Counterion: TFA
  • Delivery Format: Freeze-dried in glass vial
  • Application(s): T-cell Immunity
  • Condition(s)/Topic(s): Infection
  • Standard Delivery Time: approx. 3 weeks

JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!

Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!

References

References for Escherichia coli Beta-galactosidase 1 103-109, DAPIYTNV

References:
Read References with JPT’s Antigen Peptides
Escherichia coli Beta-galactosidase 1 103-109, DAPIYTNV has been described in:
IFN-gamma-receptor signaling ameliorates transplant vasculopathy through attenuation of CD8+ T-cell-mediated injury of vascular endothelial cells., Eur J Immunol, 2010 (PMID: 20049875)
Comprehensive assessment of determinant specificity, frequency, and cytokine signature of the primed CD8 cell repertoire induced by a minor transplantation antigen., J Immunol, 2000 (PMID: 10903727)
Antigen-delivery through invariant chain (CD74) boosts CD8 and CD4 T cell immunity., Oncoimmunology, 2019 (PMID: 30723591)

Documentation

Documentation for Escherichia coli Beta-galactosidase 1 103-109, DAPIYTNV

Properties

Properties of Escherichia coli Beta-galactosidase 1 103-109, DAPIYTNV

Properties Values
Application: T-cell immunity
Category: Antigen Peptides
Condition / Topic: Infection
Layout: Freeze-dried in glass vial
Organism: Escherichia coli
Protein Name: Beta-galactosidase
Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
Quantification: No, Yes

Further Information to Escherichia coli Beta-galactosidase 1 103-109, DAPIYTNV

Information Values
Sequence: H-DAPIYTNV-OH
Specifications: 8mer peptide as TFA salt
Loading...

Check our list of products, click and go.

Get a quote